|
FBXO22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47979999999925E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.595800E-03 |
| Normal-vs-Stage2 |
4.701600E-01 |
| Normal-vs-Stage3 |
5.90179999981899E-07 |
| Normal-vs-Stage4 |
3.53819999999727E-05 |
| Stage1-vs-Stage2 |
4.171000E-01 |
| Stage1-vs-Stage3 |
6.180000E-03 |
| Stage1-vs-Stage4 |
3.350500E-02 |
| Stage2-vs-Stage3 |
3.183800E-02 |
| Stage2-vs-Stage4 |
5.383800E-02 |
| Stage3-vs-Stage4 |
8.084000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.25909999999452E-05 |
| Normal-vs-AfricanAmerican |
1.776670E-04 |
| Normal-vs-Asian |
8.336000E-01 |
| Caucasian-vs-AfricanAmerican |
1.211040E-01 |
| Caucasian-vs-Asian |
1.792980E-01 |
| AfricanAmerican-vs-Asian |
7.431700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04469999999235E-05 |
| Normal-vs-Female |
1.781360E-03 |
| Male-vs-Female |
2.945200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.375450E-04 |
| Normal-vs-Age(41-60Yrs) |
6.021800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.774640E-04 |
| Normal-vs-Age(81-100Yrs) |
1.306370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.894190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.285190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.426400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.047000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.944800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.335200E-03 |
| Normal-vs-Grade 2 |
4.943600E-03 |
| Normal-vs-Grade 3 |
5.73680000000021E-05 |
| Normal-vs-Grade 4 |
7.55410000000678E-05 |
| Grade 1-vs-Grade 2 |
2.659400E-01 |
| Grade 1-vs-Grade 3 |
4.372800E-01 |
| Grade 1-vs-Grade 4 |
8.274600E-01 |
| Grade 2-vs-Grade 3 |
2.037600E-01 |
| Grade 2-vs-Grade 4 |
5.884000E-02 |
| Grade 3-vs-Grade 4 |
2.756200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.133900E-02 |
| Normal-vs-ccB subtype |
8.158500E-04 |
| ccA subtype-vs-ccB subtype |
1.523160E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.643500E-03 |
| Normal-vs-N1 |
9.503800E-02 |
| N0-vs-N1 |
6.608800E-01 |
|
|
